Tags: Intellectual Property

June 23, 2021


What is a trade secret? How does a trade secret differ from an intellectual property right and why choose one over the other? What measures should a company implement to best protect its trade secrets? What measures are available in the event of a breach and how can you ensure that the secret is not […]

Read on

April 29, 2021

Influencers and IP rights: Top 5 most asked practical questions by brands

Although the effectiveness of influencer marketing is now well-established, many brands are still confused about its legal aspects.

Read on

March 17, 2021

Hyperlinking and copyright law: effective technological measures are the key

The Court of Justice of the European Union has given a welcome answer to the question of under what circumstances embedding, by means of the technique of framing, should be regarded as a communication to the public that requires the copyright holder’s prior authorisation.

Read on

January 14, 2021

Champagne: in victory, one deserves it!

On 21 December 2020, the Opposition Division of the EUIPO rejected the registration application for the ‘CHAMPAWS’ trade mark for pet beverages because it evoked the ‘CHAMPAGNE’ PDO.

Read on

November 30, 2020

Precaution is not enough – CJEU finds that Cannabidiol (CBD) is not a narcotic drug

The legal status of CBD, a naturally occurring compound found in the cannabis plant, is murky. The Court has ruled that CBD is not a narcotic drug and that the principles of free movement apply.

Read on

October 19, 2020

Can a parallel importer rebrand generic medicines?

If a branded medicine and its generic version are put on the EEA market by economically-linked undertakings, is a parallel importer then allowed to rebrand and repackage the imported generic version as the branded reference medicine?

Read on

April 1, 2020

Reimbursement of medicinal products in times of pandemics and budgetary constraints: why quick fixes do not work

With national governments scrambling to take measures in order to counter the Covid-19 pandemic, we are again confronted with the fact that a EU common policy in the healthcare field is quasi inexistent.

Read on

February 12, 2020

CJEU sheds light on the “Country of Origin” concept

In the run-up to the entry into force of specific rules on country of origin labelling for primary ingredients, the CJEU has recently clarified both the concept of the “country of origin” under the FIC Regulation and its interplay with other regulations such as the Regulation on the common organisation of the agricultural products markets and the Union Customs Code.

Read on

February 3, 2020

New Belgian Act on medicinal product shortages

On 3 February 2020, the Belgian Act of 20 December 2019 amending various legal provisions concerning shortages of medicinal products was published in the Belgian State Gazette.

Read on

December 30, 2019

Patenting blockchain

While much has been written already regarding blockchain and its many exciting applications for the future, not much has been said on how you can adequately and legally protect your blockchain once it has been developed.

Read on